Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$89,088
in 5 filings, $89K under 10b5-1 plans

Net −$89,088. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-17 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +51,700 51,700
2025-06-06 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +37,500 37,500
2024-05-30 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +25,000 25,000
2024-05-13 Hopfield Jessica Director Purchase +45,000 $5.64 $254K 67,700
2023-06-01 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +25,000 25,000
2022-06-09 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +25,000 25,000
2021-06-03 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +11,538 11,538
2021-03-03 Hopfield Jessica Director Purchase +5,800 $45.51 $264K 22,700
2020-06-10 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +11,538 11,538
2019-06-12 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +11,538 11,538
2019-03-05 Hopfield Jessica Director Purchase +10,200 $23.94 $244K 16,900
2018-05-17 Hopfield Jessica Director Purchase +6,700 $37.28 $250K 6,700
2018-02-14 Hopfield Jessica Director Grant or award · Stock Option (right to buy) +23,076 23,076

Page 1 of 1 · 13 trades